Search Within

Alexander Edward Drilon

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (9)
  3. Book Section (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (19)
  2. Department of Medicine (19)
  3. GSK Faculty (19)
  4. Solid Tumor Oncology Division (19)
  5. Thoracic Oncology (19)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (16)

More Groups

People
  1. Charles Rudin (15)
  2. Mark Kris (8)
  3. Marc Ladanyi (7)
  4. Gregory Riely (6)
  5. Romel Somwar (6)
  6. Natasha Rekhtman (5)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Journal of Thoracic Oncology (5)
  2. Journal of Clinical Oncology (4)
  3. European Journal of Cancer (2)
  4. Cancer Discovery (1)
  5. JCO Precision Oncology (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. Elsevier Inc. (7)
  2. American Society of Clinical Oncology (5)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. Biomed Central Ltd (1)
  6. Elsevier Ireland Ltd. (1)

More Publishers

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers
    Meeting Abstract

    Somwar, R.; Smith, R.; Hayashi, T.; Ishizawa, K.; Charen, A. S.; Khodos, I.; Mattar, M.; He, J.; Balasubramanian, S.; Stephens, P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial
    Journal Article

    Drilon, A.; Rekhtman, N.; Arcila, M.; Wang, L.; Ni, A.; Albano, M.; Van Voorthuysen, M.; Somwar, R.; Smith, R. S.; Montecalvo, J.; more...
    Lancet Oncology (2016)

    Fulltext@MSK | Save
  • The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials
    Journal Article

    Li, B. T.; Barnes, T. A.; Chan, D. L.; Naidoo, J.; Lee, A.; Khasraw, M.; Marx, G. M.; Kris, M. G.; Clarke, S. J.; Drilon, A.; more...
    Lung Cancer (2016)

    Fulltext@MSK | Save
  • Pneumonitis with anti-PD-1/PD-L1 therapy
    Meeting Abstract

    Naidoo, J.; Cunningham, J.; Woo, K. M.; Hellmann, M. D.; Postow, M. A.; Drilon, A. E.; Chaft, J. E.; Lesokhin, A. M.; Segal, N. H.; Callahan, M. K.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Cancer biology
    Book Section

    Drilon, A. E.; Glass, J. L.; Levine, R. L.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • RET mutations in neuroendocrine tumors: Including small-cell lung cancer
    Journal Article

    Rudin, C. M.; Drilon, A.; Poirier, J. T.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage i to IIIA non-small-cell lung cancers
    Journal Article

    Drilon, A.; Sugita, H.; Sima, C. S.; Zauderer, M.; Rudin, C. M.; Kris, M. G.; Rusch, V. W.; Azzoli, C. G.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save